CASRAI Dictionary

Tag: academic research misconduct

  • Academic Misconduct in Research: Two Separate Processes

    Academic misconduct is a student-facing breach of assessment rules — plagiarism, collusion, contract cheating or fabricated coursework data — handled by a university’s student disciplinary office. Research misconduct is a narrower, professional-conduct offence covering fabrication, falsification or plagiarism (FFP) in proposing, performing or reporting research, handled by a separate research-integrity committee with its own evidentiary standard.

    The two terms get used interchangeably in casual conversation, but treating academic misconduct in research settings as one problem is a real institutional risk: it routes cases to the wrong panel and, for postgraduate researchers straddling both worlds, can leave a gap in accountability.

    Research misconduct, in the definition adopted by the US Federal Policy on Research Misconduct and applied by the Office of Research Integrity under 42 CFR Part 93, is: “fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results.” Honest error and legitimate differences of scientific opinion are explicitly excluded.

    What is academic misconduct?

    Academic misconduct is any act that gains, or attempts to gain, an unfair advantage in formal assessment. The University of Cambridge’s Discipline Regulation 7 defines it as “gaining or attempting to gain, or helping others to gain or attempt to gain, an unfair academic advantage in formal University assessment, or any activity likely to undermine the integrity essential to scholarship and research” (Cambridge Statutes and Ordinances, Chapter II, 2024 edition).

    In practice, academic misconduct covers a defined, closed list of assessment offences:

    • Plagiarism — using another person’s words, ideas or data without acknowledgement.
    • Collusion — working with others on an assessment that must be completed individually.
    • Contract cheating — paying or arranging for a third party to produce assessed work.
    • Fabrication of coursework data — inventing results for a lab report, dissertation or dataset submitted for a mark.
    • Exam-related breaches — possession of unauthorised materials or impersonation during an examination.

    A course convenor, exam board or student conduct office decides these cases, with sanctions ranging from a capped mark to expulsion.

    What is research misconduct?

    Research misconduct is a narrower category applied to the professional conduct of research itself, regardless of job title. Imperial College London’s research governance office characterises it as actions that “fall short of the standards of ethics, research and scholarship required to ensure that the integrity of research is upheld,” noting it “can cause harm to people and the environment, wastes resources, undermines the research record and damages the credibility of research.”

    The internationally recognised core is fabrication, falsification and plagiarism (FFP):

    • Fabrication — inventing data or results and recording them as real.
    • Falsification — manipulating materials, equipment, processes or images so the research record misrepresents what was actually done.
    • Plagiarism — appropriating another researcher’s ideas, methods or results without credit, in a published or submitted work.

    Wider “questionable research practices” — gift or ghost authorship, salami-slicing, undisclosed conflicts of interest — sit outside the strict FFP definition but are increasingly folded into research-integrity policy. Robust use of the CRediT contributor role taxonomy, which CASRAI originated in 2014 and which NISO now stewards as ANSI/NISO Z39.104-2022, is one practical way institutions pre-empt gift-authorship disputes before they escalate.

    Why do institutions run two separate processes?

    Academic and research misconduct sit in different regulatory lineages, so institutions build separate committees and policies rather than one catch-all procedure.

    Dimension Academic misconduct Research misconduct
    Typical subject Registered student, any level Principal investigator, postdoc, established researcher
    Core acts Plagiarism, collusion, contract cheating, exam breaches Fabrication, falsification, plagiarism (FFP)
    Governing framework University disciplinary regulations / exam conventions Institutional research-integrity policy under the Concordat to Support Research Integrity (Universities UK, revised 2019); in the US, 42 CFR Part 93
    Decision body Exam board, student conduct office Dedicated research-integrity or research-misconduct committee, often with external assessors
    Typical sanctions Mark penalty, module fail, suspension, expulsion Correction or retraction, funding clawback, research ban, referral to a professional register
    External reporting Rarely reported outside the institution Often reportable to funders (e.g. UKRI), publishers and, for clinical research, regulators

    The UK has no statutory equivalent of the US Office of Research Integrity. Instead, UKRIO, founded in 2006, provides advisory guidance while institutions retain investigatory responsibility under their own research-misconduct policy, as required by the Concordat.

    Where does the line blur for postgraduate researchers?

    The clean split breaks down precisely where most CASRAI readers work: the PhD candidate who is simultaneously a registered student and an author generating primary research data.

    Cambridge’s own regulation illustrates the overlap directly. Discipline Regulation 7 folds research-conduct failures into the academic misconduct definition, explicitly including “fabrication, falsification or misrepresentation of data, results or other outputs or aspects of research” and “failure to meet legal, ethical and professional obligations in carrying out research.” That means conduct that would be classic FFP research misconduct if committed by a principal investigator is processed through the student disciplinary system when the person responsible is a registered student.

    This is not a Cambridge quirk. UKRIO’s April 2024 guidance, Research Integrity Matters Relating to Students, was published because institutions across the sector were struggling to decide whether a doctoral candidate’s data-fabrication allegation should go through student discipline or the research-misconduct committee — and because degrees already awarded can be affected by findings made years later.

    The ambiguity is not new. A widely cited 2008 study in Studies in Higher Education (Mitchell and colleagues, cited by 89 in Google Scholar) found that misconduct during doctoral study is difficult to resolve “because of lack of clarity in definitions, supervisor naïveté and failure to acknowledge students’ [research-conduct failures]” as distinct from ordinary academic misconduct. A 2024 conceptual review in the same journal (Harrad, cited by 22) found that framing a case as “academic integrity” foregrounds ethics and values, while framing it as “academic misconduct” foregrounds illegitimate advantage — a distinction that shapes which committee, and which burden of proof, a postgraduate case ends up under.

    Institutions that get this right build an explicit triage step into their research administration workflow: does the disputed conduct sit in assessed coursework (student discipline) or in the primary research record intended for publication or a thesis contribution (research-misconduct policy)? The same underlying act can trigger both processes in parallel, so the routing decision needs to be documented, not assumed.

    Answer-first Q&A

    What qualifies as academic misconduct?

    Academic misconduct is any act that gains, or helps another gain, an unfair advantage in formal assessment. It includes plagiarism, collusion, contract cheating, fabricated coursework data, and exam-related breaches such as possessing unauthorised materials, regardless of whether the student intended to cheat.

    What are examples of research misconduct?

    Classic examples include inventing data for a clinical trial that never took place, manipulating a Western blot image to fit a hypothesis, and plagiarising another researcher’s methods or results in a submitted manuscript. All three fall under the fabrication, falsification and plagiarism (FFP) definition used by research-integrity policy.

    What are the five unethical practices in research?

    A frequently cited framework lists falsification of data, failure to credit others, plagiarism, undisclosed conflicts of interest, and biased design or interpretation driven by outside influence. Only the first and third meet the strict FFP definition of research misconduct; the rest are treated as questionable research practices.

    How hard is it to prove academic dishonesty?

    Both academic and research misconduct cases in UK higher education are generally decided on the civil balance of probabilities, not the criminal standard. Proving intent is harder than proving the act itself, which is why panels focus on documentary evidence — submission logs, raw data files, similarity reports — rather than motive.

    What this means for institutions

    For research administrators and institutional leaders, a single “misconduct policy” covering both students and PIs under one procedure will consistently mis-route the hardest cases — postgraduate researchers — because it cannot specify which evidentiary standard and which committee applies to a thesis chapter versus an exam script.

    The forward-looking fix, already visible in UKRIO’s 2024 guidance and in policies revised against the Concordat to Support Research Integrity, is an explicit triage protocol naming both process owners and stating when a case is reportable to a funder such as UKRI, when it is reportable to a publisher under Committee on Publication Ethics (COPE) guidance, and when it stays internal. Clear authorship attribution at the outset of a project remains one of the cheapest ways to prevent disputes reaching either committee at all.

  • Federal Research Misconduct Rules: Lehigh’s 2026 Policy Model

    Research misconduct according to federal regulations means fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting results — the standard set by 42 CFR Part 93 and enforced by the Department of Health and Human Services’ Office of Research Integrity (ORI). A revised version of that rule took effect for allegations received on or after 1 January 2026, and Lehigh University’s newly effective policy shows what compliance looks like in practice.

    Research misconduct is fabrication, falsification, or plagiarism (FFP) committed intentionally, knowingly, or recklessly in proposing, performing, reviewing, or reporting research — not honest error or a legitimate difference of scientific opinion.

    What Counts as Research Misconduct Under Federal Regulations?

    Under 42 CFR Part 93, research misconduct requires three elements to co-exist: a significant departure from accepted practices in the relevant research community, intent (committed intentionally, knowingly, or recklessly), and proof by a preponderance of the evidence. All three must be satisfied — a mistake alone, without intent, is not misconduct.

    The regulation names three specific acts, commonly abbreviated FFP:

    • Fabrication — making up data or results and recording or reporting them.
    • Falsification — manipulating research materials, equipment, or processes, or changing or omitting data so the research record is not accurately represented.
    • Plagiarism — appropriating another person’s ideas, processes, results, or words without giving appropriate credit.

    The Office of Research Integrity, part of HHS, oversees Public Health Service (PHS)-funded research, while the National Science Foundation applies a near-identical definition to its own awards. Financial conflicts of interest, authorship disputes, and general workplace misconduct fall outside this federal definition, even where an institution’s own policy treats them separately.

    What Changed Under the 2026 Public Health Service Rule?

    HHS published a final rule revising 42 CFR Part 93 in the Federal Register on 17 September 2024 — the first substantive update since 2005. Under the rule, institutions must apply the new requirements to any allegation of research misconduct received on or after 1 January 2026; allegations received earlier remain governed by the 2005 text.

    The revision responds to two decades of practical drift between the 2005 text and how research is actually conducted and investigated. Its most consequential changes include:

    • The maximum time to complete an inquiry rises from 60 to 90 calendar days.
    • The maximum time to complete an investigation, including drafting the final report, rises from 120 to 180 calendar days.
    • Institutions may now use a Research Integrity Officer or another designated official to conduct an inquiry, rather than being required to convene a separate inquiry committee.
    • “Intentionally,” “knowingly,” and “recklessly” receive codified definitions, and plagiarism is defined to exclude self-plagiarism and authorship disputes.
    • Institutions gain clearer authority to disclose respondent, complainant, and witness identities to parties with a “legitimate need,” including journals, editors, and collaborating institutions.

    ORI has told institutions they must submit policies and procedures that comply with the final rule alongside their annual report covering the 2025 calendar year, due on or before 30 April 2026 — giving research offices a hard, near-term compliance checkpoint even where no allegation has yet been received under the new rule.

    How Lehigh University Rebuilt Its Policy Around the New Rule

    Lehigh University’s Office of the Vice Provost for Research finalised a rewritten Research Misconduct Policy effective 1 January 2026, timed to the federal applicability date. Rather than a quiet administrative update, Lehigh ran the revision through a faculty working group with one representative per college, presented the draft to Faculty Senate in November 2025, and opened a public comment period before finalising the text — a governance pattern other institutions can replicate ahead of their own compliance deadline.

    Who the Policy Covers and Who Runs It

    The policy applies to all faculty, emeritus faculty, academic and professional staff, students, and independent contractors conducting research at Lehigh, regardless of whether the work is federally funded. A designated Research Integrity Officer (RIO) administers assessments, inquiries, and investigations, while a Deciding Official — ordinarily the Vice Provost for Research — makes the final determination and imposes any sanction, subject to a conflict-of-interest recusal.

    Standard of Proof and Time Limits

    Findings must be proved by a preponderance of the evidence, with the burden of proof resting on the university rather than the accused researcher. Lehigh’s policy also carries a six-year time limitation on allegations, with exceptions where a continuing public health threat exists or where fabricated material is knowingly reused in a later, federally funded application. Institutional records must be retained for seven years following the close of a proceeding.

    Lehigh’s Timelines Against the Federal Ceiling

    The table below sets Lehigh’s adopted timelines directly against the federal maximums the 2026 rule now permits — a comparison the generic explainer pages on this topic do not make, because most predate Lehigh’s finalised text.

    Process stage Federal ceiling (42 CFR Part 93, 2026) Lehigh University policy
    Assessment of a complaint Not federally timed Preferably within 1 week
    Inquiry 90 calendar days 90 calendar days
    Investigation 180 calendar days 180 calendar days
    Respondent appeal Not federally required 15 days from final decision
    Time limitation on allegations 6 years (with exceptions) 6 years (with matching exceptions)
    Record retention post-proceeding Institutional discretion 7 years

    Two design choices stand out. First, Lehigh set its inquiry and investigation clocks at exactly the new federal ceilings rather than building in a stricter internal buffer — a defensible but notable choice research administrators at other institutions should weigh against their own caseload and staffing. Second, Lehigh added a 15-day respondent appeal window and a 7-year retention rule that the federal regulation does not itself mandate, addressing due-process and evidentiary gaps institutions have raised informally with ORI since 2005.

    Frequently Asked Questions

    What is the federal definition of research misconduct?

    The federal definition is fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting results, under 42 CFR Part 93. A finding also requires a significant departure from accepted practice, intent, and proof by a preponderance of the evidence.

    What are the three types of research misconduct?

    The three recognised types are fabrication (inventing data), falsification (manipulating data, materials, or processes so the record misrepresents the research), and plagiarism (using another person’s words, ideas, or results without credit). Together they form the “FFP” standard used across US federal agencies.

    What is the US federal research misconduct policy?

    The US federal policy is set out in 42 CFR Part 93, administered by the HHS Office of Research Integrity for Public Health Service-funded research. A 2024 final rule revised the policy for the first time since 2005, applying to allegations institutions receive on or after 1 January 2026.

    What This Means for Other Institutions

    Lehigh’s rewrite is a useful reference point because it shows the rule’s flexibility resolved into concrete, adoptable choices rather than remaining abstract. Institutions still finalising their own policies ahead of the 30 April 2026 annual-report deadline can treat Lehigh’s structure — RIO-led assessment, a fixed appeal window, and matched federal timelines — as one workable template, without needing to invent a compliance architecture from scratch.

    The broader implication for research administration teams is procedural, not just definitional: the 2026 rule shifts discretion toward institutions on committee composition and disclosure, while tightening documentation and timeline expectations. Offices that treat this as solely a definitions update — rather than a governance and record-keeping one — risk falling short of ORI’s annual reporting requirement even if no misconduct allegation is ever filed under the new text.

  • How to Avoid Research Misconduct: PhD Checklist

    How to avoid research misconduct as an early-career researcher comes down to five habits: keep verifiable records from day one, agree authorship and CRediT roles before writing starts, retain data for the period your funder requires, disclose every conflict of interest, and know your institution’s reporting route before you ever need it. Research misconduct is the fabrication, falsification, or plagiarism of data, results, or other people’s work in proposing, performing, reviewing, or reporting research — a definition used by the US Office of Research Integrity and echoed by the UK Research Integrity Office (UKRIO).

    PhD students and postdocs face specific pressure points that senior investigators rarely encounter in the same way: unclear authorship expectations, ambiguous data ownership when moving labs or institutions, and thin knowledge of funder-specific retention rules. This guide sets out an individual-level checklist — not an institutional policy document — for the two career stages where most avoidable misconduct risk actually sits.

    What is research misconduct?

    The US Office of Research Integrity defines research misconduct as fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results — and explicitly excludes honest error or genuine differences of scientific opinion. UKRIO uses a broader formulation: behaviours that deliberately or recklessly fall short of the standards expected in the conduct of research.

    • Fabrication — inventing data or results that were never generated.
    • Falsification — manipulating materials, equipment, processes, or data so the research record misrepresents what actually happened.
    • Plagiarism — using another person’s ideas, words, or results without appropriate credit.

    Below these three formal categories sit questionable research practices (QRPs) that rarely trigger a formal misconduct finding but do real damage: salami-slicing a single dataset into multiple papers, gift or ghost authorship, undisclosed conflicts of interest, and selective reporting of results. Early-career researchers are disproportionately exposed to QRPs because they typically have the least authority to push back when a supervisor or collaborator proposes one.

    The early-career checklist: how to avoid research misconduct

    Prevention at the individual level works best as a small number of fixed habits applied consistently, rather than a one-off training module. The checklist below groups those habits into the three areas where early-career researchers are most exposed: record-keeping, authorship, and disclosure.

    Data retention and record-keeping

    Keep a dated, tamper-evident record of every experiment, dataset version, and analysis script — electronic lab notebooks and version-controlled repositories are far easier to defend under scrutiny than a personal laptop folder. Retention periods are not optional extras; they are usually written into your funding agreement. UKRI’s grant Terms and Conditions require standard research data to be retained for a minimum of ten years from the date the last researcher on the project drew on it, with longer retention commonly required for clinical or patient-identifiable data. Before you leave a lab or finish a contract, confirm who takes custodial responsibility for the data and archive it through your institutional repository rather than a personal drive.

    Authorship sign-off using CRediT

    Disputed or inflated authorship is one of the most common sources of misconduct allegations against early-career researchers, usually because it was never discussed until submission. Raise authorship expectations at the start of a project, not the end, and record who did what using a recognised contributor taxonomy. CASRAI originated the CRediT contributor role taxonomy in 2014; the standard is now stewarded by NISO as ANSI/NISO Z39.104-2022. Alongside CRediT, the International Committee of Medical Journal Editors (ICMJE) sets four authorship criteria — substantial contribution, drafting or critical revision, final approval, and accountability for accuracy — all of which should be satisfied and confirmed in writing before a manuscript is submitted. See CASRAI’s overview of the CRediT taxonomy and individual contributor roles, and the broader guidance on authorship practice.

    Disclosure habits: conflicts of interest and funding

    Declare funding sources, consultancy income, and any relationship that could be perceived to bias your work — on every manuscript, grant application, and peer-review invitation, not just the ones where a conflict feels obvious. Undisclosed conflicts of interest are one of the categories of unethical practice identified in the research-ethics literature alongside fabrication, falsification, plagiarism, and biased design or interpretation. Build a habit of updating your disclosure statement annually rather than reconstructing it from memory when an editor asks.

    Practice area PhD student focus Postdoc focus
    Data management Agree a data management plan and storage location with your supervisor at project start Confirm retention complies with the funder’s terms (e.g. UKRI’s minimum ten-year rule) and archive before your contract ends
    Authorship Discuss authorship order and CRediT roles with your supervisor before drafting begins Lead authorship conversations for your own team and confirm every contributor’s CRediT role before submission
    Disclosure Declare your funding source and any external roles on every submission Disclose conflicts of interest on grant applications and review invitations; update annually
    Raising concerns Know your university’s research integrity or whistleblowing contact Signpost concerns to UKRIO’s confidential advisory service or the relevant COPE flowchart

    Common questions on avoiding research misconduct

    How can research misconduct be prevented?

    Prevention combines individual habits with institutional support: complete responsible conduct of research training, keep a verifiable data record from the outset, agree authorship and disclosure expectations early, and use a named mentor to check difficult decisions before they become irreversible.

    What are the 5 unethical practices in research?

    The research-ethics literature commonly lists five categories: fabrication of data, falsification of results, plagiarism of others’ work, failure to credit contributors, and undisclosed conflicts of interest that bias design or interpretation.

    How can we prevent unethical research?

    Reduce bias systematically: pre-register study design where possible, separate data collection from data interpretation roles, declare every conflict of interest, and keep records detailed enough that a colleague could reconstruct your analysis without asking you a single question.

    What to do if you suspect misconduct

    Early-career researchers are frequently the first to notice irregularities — and often the least sure how to act on them without risking their own position. UKRIO operates a free, confidential advisory service specifically to help individuals think through a concern before deciding whether to raise it formally, independent of any single university’s internal process. The Committee on Publication Ethics (COPE) publishes decision flowcharts that editors and institutions use to work through suspected data fabrication, image manipulation, and authorship disputes; reading these in advance demystifies what a formal process actually involves.

    • Raise concerns informally with a trusted mentor first, where safe to do so.
    • Use your institution’s named research integrity contact for a formal report.
    • Contact UKRIO’s advisory service for independent, confidential guidance if you are unsure whether a concern meets the threshold for misconduct.
    • Document your concern in writing, with dates, before raising it — memory fades and paper trails protect everyone involved.

    Building a habit of research integrity

    None of the five habits above require institutional permission to start. A PhD student can open a data management plan, propose a CRediT-based authorship discussion, and file a disclosure statement without waiting for a policy update. What changes between PhD and postdoc stage is not the principle but the stakes: postdocs increasingly lead the projects, supervise the juniors, and sign the disclosures that PhD students are only learning to draft. Starting the habit early is what keeps it intact when the stakes rise.

  • How to Prevent Research Misconduct: What Works Beyond Training

    How to prevent research misconduct is a design question, not a compliance checkbox: the evidence base shows that one-off training courses produce little durable change in behaviour, while combining structured mentoring, routine data-audit sampling, and mandatory statement-of-contribution sign-off measurably narrows the gaps where fabrication, falsification, and plagiarism occur. Research misconduct is the fabrication, falsification, or plagiarism of research data, methods, or results — the definition used by the US Office of Research Integrity (ORI) and mirrored in UK Research Integrity Office (UKRIO) guidance. This analysis sets out, for research integrity leads shaping programme design, which interventions carry more evidence of effect than a single training module, and how to sequence them.

    What actually prevents research misconduct beyond training?

    Institutions reduce research misconduct most effectively by layering structural controls that make dishonesty harder to commit and easier to detect, rather than relying on researchers to internalise a code of conduct after a single session. The controls with the strongest design logic are mentoring embedded in day-to-day supervision, sampled audits of raw data, and a signed statement of contribution attached to every output.

    Each targets a different failure point. Mentoring addresses the socialisation gap that leaves early-career researchers guessing at norms. Audit sampling addresses the detection gap that lets fabricated data go unchecked for years. Contribution sign-off addresses the accountability gap that allows honorary or ghost authorship to obscure who is actually answerable for a claim.

    Why compliance training alone falls short

    The strongest available synthesis on this question is a 2016 Cochrane review by Marušić and colleagues, Interventions to Prevent Misconduct and Promote Integrity in Research and Publication, which evaluated educational and policy interventions in responsible conduct of research. The review found the certainty of evidence for training-based interventions was very low, and could not confirm that classroom-style courses produce sustained change in research behaviour once the session ends.

    This matters for programme design because most institutional integrity budgets still concentrate on a single onboarding module. A widely cited meta-analysis by Fanelli (2009, PLoS ONE) found that 1.97% of scientists admitted to fabricating or falsifying data at least once, while up to 33.7% admitted other questionable research practices such as selective reporting — behaviours a compliance quiz is poorly placed to change, because they are driven by publication pressure and weak oversight, not ignorance of the rules.

    • Training transmits definitions (what counts as fabrication, falsification, plagiarism) but rarely changes incentives.
    • Effects measured immediately after training decay within months, per the Cochrane review’s own included studies.
    • Training has no detection function — it does not catch misconduct already occurring.

    Which interventions show more effect than training

    No single intervention is sufficient on its own; the practical task for a research integrity lead is combining measures whose costs and detection functions differ, so that gaps in one are covered by another.

    Intervention Primary function Evidence basis Relative institutional cost
    One-off compliance training Awareness of definitions and reporting routes Very low-certainty evidence of sustained behaviour change (Marušić et al., 2016) Low
    Structured mentoring embedded in supervision Socialisation into disciplinary norms; early flagging of questionable practice Consistently associated with lower reported misconduct risk in survey-based studies included in the Cochrane review Medium — requires supervisor time allocation
    Data-audit sampling Detection of fabrication/falsification before publication Standard practice recommended by COPE and UKRIO; used by ORI in federal misconduct findings Medium-high — requires trained auditors
    Statement-of-contribution sign-off (CRediT-based) Accountability — closes ghost/honorary authorship gaps Required by ICMJE’s accountability criterion; adopted in journal policy across major publishers Low — process change, not new staff
    Standing research integrity office / confidential channel Independent investigation and retaliation-free reporting Recommended under the UK Concordat to Support Research Integrity (2019) High — dedicated role or committee

    UKRIO, the UK’s independent advisory body on research integrity, operates alongside the Concordat to Support Research Integrity, which more than 100 UK higher education institutions and funders have signed since 2019 through Universities UK. The Concordat’s five commitments — from fostering a research environment to investigating allegations rigorously — map closely to the table above: none of them is satisfied by training alone.

    Designing a statement-of-contribution sign-off process

    A statement-of-contribution sign-off requires every named contributor to attest, before submission, to the specific role they played and to accept accountability for that portion of the work. This directly answers ICMJE’s fourth authorship criterion — agreement to be accountable for the accuracy and integrity of the work — which training cannot enforce because it depends on a process, not knowledge.

    The taxonomy most institutions use to structure this sign-off is CRediT (Contributor Roles Taxonomy). CASRAI originated the CRediT taxonomy in 2014; the standard is now stewarded by NISO as ANSI/NISO Z39.104-2022, with fourteen defined contributor roles spanning conceptualisation, data curation, formal analysis, and more.

    Practical design steps for a research integrity lead:

    1. Mandate role declaration at manuscript submission, not at the review stage, so disputes surface before publication.
    2. Require each contributor to sign off individually rather than accept a single corresponding-author declaration on their behalf.
    3. Log declarations centrally so audit sampling can cross-check role claims against actual data-access records.
    4. Pair sign-off with the department’s mentoring structure, so early-career researchers understand what each role entails before they attest to one.

    Institutions building this into policy can reference the underlying role definitions and contributor-role pages for internal training materials.

    Common questions on preventing research misconduct

    What is the most effective strategy for preventing research misconduct?

    No single strategy stands alone. The 2016 Cochrane review found the strongest combination pairs structured mentoring, routine data-audit sampling, and mandatory contribution sign-off, reinforced by leadership that treats integrity as an ongoing institutional practice rather than a one-time compliance event.

    How can we prevent unethical research?

    Preventing unethical research requires layered safeguards: clear authorship and data-management policies, a confidential reporting channel protected from retaliation, and independent oversight such as a research integrity office. Institutions combining these with periodic review of raw datasets catch problems earlier than training-only programmes.

    What are the 5 unethical practices in research?

    The most commonly cited unethical practices are fabrication and falsification of data, plagiarism, undisclosed conflicts of interest, and failure to credit contributors. ORI defines the first three as FFP — fabrication, falsification, plagiarism — the formal basis for US federal misconduct findings.

    How can research misconduct be prevented?

    Research misconduct is reduced most reliably through overlapping structural controls, not persuasion alone: mandatory statement-of-contribution sign-off, periodic audit sampling of raw data, mentoring embedded in supervision, and a standing integrity office with authority to investigate — each covering a gap that training by itself leaves open.

    For research integrity leads, the implication for programme design is direct: budget for detection and accountability mechanisms, not only awareness. A training module remains necessary as an entry point, but treating it as the whole programme leaves the exact failure modes — fabrication, falsification, ghost authorship — uncovered. As funders and publishers increasingly require documented contributor roles and data-management plans, institutions that have already embedded audit sampling and sign-off into routine practice will meet those requirements as a by-product of good design, rather than scrambling to retrofit them.

  • Research Misconduct Case Studies: The 3-Stage Investigation Pattern

    Research misconduct case studies, read across institutions and years rather than one scandal at a time, show a repeatable pattern: a three-stage process (assessment, inquiry/investigation, appeal), a civil “preponderance of the evidence” standard rather than criminal proof, and appeal routes that vary sharply between the United States, the United Kingdom, and the European Union. Benchmarking against this pattern — not against any single named case — is what lets a research integrity officer (RIO) judge whether their own procedure is fit for purpose.

    A research misconduct case is formally defined, under the United States’ federal regulation for Public Health Service (PHS)-funded research, as fabrication, falsification, or plagiarism (FFP), committed intentionally, knowingly, or recklessly. This article sets aside individual identities and instead compares the procedural architecture that concluded cases reveal, so integrity officers and research administration teams can stress-test their own workflow against a documented, cross-jurisdictional standard. Related terminology is catalogued in the CASRAI research administration dictionary.

    What the three-stage investigation process reveals

    Every concluded United States case that falls under PHS funding follows the same skeleton set out in the federal research misconduct regulation, 42 CFR Part 93. Stripped of case-specific detail, the pattern is procedural, not narrative, and it repeats regardless of discipline or seniority of the respondent.

    1. Assessment. The institution’s Research Integrity Officer screens the allegation to confirm it falls within the FFP definition and that the accused conducted the work under covered funding.
    2. Inquiry. A preliminary, fact-finding review determines whether a full investigation is warranted. Under 42 CFR §93.307, institutions are expected to complete the inquiry within 60 days of initiation, extendable only with a documented justification in the record.
    3. Investigation. A committee examines sequestered research records, notebooks, and raw data in full. Per 42 CFR §93.311, the Office of Research Integrity (ORI) expects institutions to complete this stage within 120 days, with the respondent given an opportunity to comment on the draft report before it is finalised.

    The consistency of this three-stage architecture across decades of closed ORI case summaries is itself the diagnostic tool: cases that stall well past 60 or 120 days, or skip straight from allegation to sanction without a documented inquiry, are the ones most likely to be overturned on appeal.

    What standard of proof applies in research misconduct cases

    Research misconduct findings are civil, not criminal, determinations. Under 42 CFR §93.106(b), a finding requires proof by a preponderance of the evidence — that the alleged conduct is more likely than not to have occurred — rather than the “beyond reasonable doubt” threshold used in criminal law.

    Three elements must all be satisfied for a finding to stand:

    • The conduct represents a significant departure from accepted practices in the relevant research community.
    • The act was committed intentionally, knowingly, or recklessly — honest error and legitimate differences of scientific interpretation are explicitly excluded.
    • The allegation is proven by a preponderance of the evidence assembled during the inquiry and investigation stages.

    This is a materially lower bar than criminal fraud statutes, which is precisely why institutions can act on data-integrity concerns years before — or entirely without — any parallel criminal or civil litigation. In the United Kingdom, no single statutory standard applies; the Concordat to Support Research Integrity, published by Universities UK, commits signatory institutions to “robust and fair” procedures but leaves the specific evidentiary threshold to each institution’s own disciplinary regulations, typically the civil “balance of probabilities” test familiar from UK employment law.

    What appeal routes exist after a misconduct finding

    Appeal architecture is where the US and UK systems diverge most sharply, and it is the least-benchmarked part of most institutional policies.

    In the US federal system, a respondent facing a proposed debarment or suspension of federal funding eligibility can request a hearing before a Departmental Appeals Board (DAB) Administrative Law Judge, under the appeal provisions of 42 CFR Part 93, Subpart D. The ALJ hearing allows both ORI and the respondent to present evidence, and courts have previously found in favour of respondents where an agency denied a hearing without adequate justification — underscoring that procedural due process, not just the underlying evidence, is independently reviewable.

    In the UK, there is no equivalent national appellate body. Appeals run through each institution’s own internal grievance or disciplinary panel, sitting outside the original investigating committee. UKRIO offers independent advisory input on request but has no statutory power to overturn or reopen a case. Where a funder, rather than an employer, makes the finding — for instance under a UKRI grant condition — the appeal route sits with the funder’s own review process, separate from the host institution’s route.

    How timelines and procedures compare across jurisdictions

    The table below compares the procedural pattern documented in concluded cases across the three frameworks a UK-based or internationally funded institution is most likely to encounter.

    Framework Governing document Recommended timeline Standard of proof Appeal route
    US federal (PHS-funded) 42 CFR Part 93 (ORI) Inquiry: 60 days; Investigation: 120 days Preponderance of the evidence HHS Departmental Appeals Board ALJ hearing
    UK institutional Concordat to Support Research Integrity (Universities UK) Set by each institution’s own policy; no fixed statutory deadline Balance of probabilities (institution-defined) Internal grievance/appeal panel; UKRIO advisory only
    EU / Horizon Europe European Code of Conduct for Research Integrity (ALLEA, revised 2023) Left to national/institutional implementation Not standardised; varies by member state National research integrity body or institutional route, depending on country

    The gap this table exposes is one most institutional policies fail to acknowledge in writing: US regulation fixes an evidentiary standard and a timeline in federal law, while UK and EU frameworks fix principles but delegate both to the institution or member state. For an internationally funded research group, the applicable standard of proof can therefore change depending on which funder paid for the disputed work — a fact case files consistently reveal once cross-border co-authorship is involved.

    Frequently asked questions

    What counts as research misconduct in a case study?

    Under US federal regulation and the frameworks it has influenced internationally, research misconduct is defined as fabrication, falsification, or plagiarism (FFP) committed intentionally, knowingly, or recklessly. It excludes honest error, authorship disputes, and good-faith differences in data interpretation or experimental design.

    How long does a research misconduct investigation take?

    Under 42 CFR Part 93, US institutions are expected to complete an inquiry within 60 days and a full investigation within 120 days of initiation. UK and EU frameworks set no equivalent statutory deadline, so timelines vary considerably by institution and case complexity.

    What standard of proof is used to find research misconduct?

    The applicable US standard is a preponderance of the evidence — more likely than not — rather than criminal-level proof. UK institutions typically apply the analogous civil balance of probabilities test under their own disciplinary regulations, since no single UK statutory standard exists.

    Can a researcher appeal a research misconduct finding?

    Yes. US respondents facing federal debarment can request a hearing before an HHS Departmental Appeals Board Administrative Law Judge. UK researchers appeal through their institution’s internal grievance or disciplinary panel, since no national appellate body for misconduct findings currently exists.

    What this means for research integrity officers

    Reading concluded cases for procedural pattern, rather than for scandal detail, produces a practical benchmarking checklist that any RIO can apply to their own institution’s policy:

    • Does the policy document a fixed inquiry and investigation timeline, and is it consistently met in closed cases?
    • Is the standard of proof — preponderance of the evidence or balance of probabilities — stated explicitly, rather than implied?
    • Is the appeal route independent of the original investigating committee, with named escalation steps?
    • Where research is co-funded across US, UK, or EU sources, does the policy specify which framework’s standard applies?
    • Are sequestration procedures for research records triggered automatically at the inquiry stage, not the investigation stage?

    Institutions that can answer all five points in writing sit closer to the documented federal pattern than those relying on ad hoc, case-by-case discretion — and case files show procedural gaps, not evidentiary weakness, are the most common ground on which findings are successfully challenged. As research increasingly crosses funder and jurisdictional boundaries, benchmarking process design against this comparative pattern, rather than against any single high-profile case, is becoming a core, auditable component of institutional research governance.